Hydroxypropyl Methylcellulose Phthalate: What is it

Hydroxypropyl Methylcellulose Phthalate: What is it

Hydroxypropyl Methylcellulose Phthalate (HPMCP) is a modified cellulose derivative that is commonly used in the pharmaceutical industry. It is derived from Hydroxypropyl Methylcellulose (HPMC) through further chemical modification with phthalic anhydride. This modification imparts unique properties to the polymer, making it suitable for specific applications in drug formulation.

Here are key characteristics and applications of Hydroxypropyl Methylcellulose Phthalate:

  1. Enteric Coating:
    • HPMCP is widely used as an enteric coating material for oral dosage forms such as tablets and capsules.
    • Enteric coatings are designed to protect the drug from the acidic environment of the stomach and facilitate release in the more alkaline environment of the small intestine.
  2. pH-Dependent Solubility:
    • One of the distinctive features of HPMCP is its pH-dependent solubility. It remains insoluble in acidic environments (pH below 5.5) and becomes soluble in alkaline conditions (pH above 6.0).
    • This property allows the enteric-coated dosage form to pass through the stomach without releasing the drug and then dissolve in the intestines for drug absorption.
  3. Gastric Resistance:
    • HPMCP provides gastric resistance, preventing the drug from being released in the stomach where it may be degraded or cause irritation.
  4. Controlled Release:
    • In addition to enteric coating, HPMCP is used in controlled-release formulations, allowing for a delayed or extended release of the drug.
  5. Compatibility:
    • HPMCP is generally compatible with a wide range of drugs and can be used in various pharmaceutical formulations.

It’s important to note that while HPMCP is a widely used and effective enteric coating material, the choice of enteric coating depends on factors such as the specific drug, desired release profile, and patient requirements. Formulators should consider the physicochemical properties of both the drug and the enteric coating material to achieve the desired therapeutic outcome.

As with any pharmaceutical ingredient, regulatory standards and guidelines should be followed to ensure the safety, efficacy, and quality of the final pharmaceutical product. If you have specific questions about the use of HPMCP in a particular context, it’s recommended to consult relevant pharmaceutical guidelines or regulatory authorities.


Post time: Jan-22-2024